US SB4390 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on June 14 2022 - 25% progression, died in committee
Action: 2022-06-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 14 2022 - 25% progression, died in committee
Action: 2022-06-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require summary approval information with respect to certain approved drugs and biological products.
Title
Accelerated Approval Transparency Act
Sponsors
| Sen. John Hickenlooper [D-CO] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-06-14 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/senate-bill/4390/all-info |
| Text | https://www.congress.gov/117/bills/s4390/BILLS-117s4390is.pdf |
